Impact of Antifungal Compounds on Viability and Anti- Aspergillus Activity of Human Natural Killer Cells | Zendy

Stanislaw Schmidt | Zendy; Ralf Schubert | Zendy; Lars Tramsen | Zendy; Thomas Lehrnbecher | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Impact of Antifungal Compounds on Viability and Anti- Aspergillus Activity of Human Natural Killer Cells

Author(s) -

Stanislaw Schmidt,

Ralf Schubert,

Lars Tramsen,

Thomas Lehrnbecher

Publication year - 2018

Publication title -

antimicrobial agents and chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.07

H-Index - 259

eISSN - 1070-6283

pISSN - 0066-4804

DOI - 10.1128/aac.01993-18

Subject(s) - aspergillosis , antifungal , natural killer cell , aspergillus , adoptive cell transfer , immunology , in vitro , biology , haematopoiesis , aspergillus fumigatus , microbiology and biotechnology , hematopoietic stem cell transplantation , hematopoietic cell , immune system , stem cell , cytotoxicity , t cell , biochemistry , genetics

Despite the availability of new antifungal compounds, invasive aspergillosis carries high morbidity and mortality in hematopoietic stem cell transplant recipients.In vitro studies and animal models suggest that the adoptive transfer of natural killer (NK) cells might be a promising immunotherapeutic option in this setting.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research